GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes

INTRODUCTION: Experimentally, gamma-aminobutyric acid (GABA) has been found to exert immune-modulatory effects and induce beta-cell regeneration, which make it a highly interesting substance candidate for the treatment of type 1 diabetes (T1D). In many countries, including those in the European Unio...

Descripción completa

Detalles Bibliográficos
Autores principales: Espes, Daniel, Liljebäck, Hanna, Hill, Henrik, Elksnis, Andris, Caballero-Corbalan, José, Birnir, Bryndis, Carlsson, Per-Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506884/
https://www.ncbi.nlm.nih.gov/pubmed/34635547
http://dx.doi.org/10.1136/bmjdrc-2021-002442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506884/
https://www.ncbi.nlm.nih.gov/pubmed/34635547
http://dx.doi.org/10.1136/bmjdrc-2021-002442

Ejemplares similares